Nissen E, Tanneberger S, Projan A, Morack G, Peek U
Arch Geschwulstforsch. 1978;48(7):667-72.
To assess the clinical value of the organ culture drug prediction assay in the present study we summarize the results of two randomized trials in lung carcinoma (61 patients) and ovarian carcinoma (74 patients) comparing predicted and non-predicted or no surgical adjuvant chemotherapy. No real progress could be achieved by predicted cancer chemotherapy. The reasons of the negative results of our studies are discussed.
为评估本研究中器官培养药物预测试验的临床价值,我们总结了两项分别针对肺癌(61例患者)和卵巢癌(74例患者)的随机试验结果,这两项试验比较了预测性化疗与非预测性或未进行手术辅助化疗的情况。预测性癌症化疗未能取得实际进展。我们讨论了研究结果为阴性的原因。